ngµç×ÓÓÎÏ·

03
½Ìѧ¿ÆÑÐ
  • 07 2026-01

    ngµç×ÓÓÎÏ·ÑîÁ®Æ½ÍŶÓÁªºÏÇ廪´óѧ¼Í˼º²ÍŶÓϵͳÆÊÎöÌìÆø×ª±ä¶ÔÎ÷̫ƽÑóµØÇø¿¹ÉúËØÄÍÒ©ÐÔµÄÓ°Ïì

    ngµç×ÓÓÎÏ·ÐÂÎÅÍø£¨Í¨Ñ¶Ô± Âí×ÓÊæ£¬£¬ÃÏ·²Ü·£©¿ËÈÕ£¬£¬ngµç×ÓÓÎÏ·¹«¹²ÎÀÉúѧԺÑîÁ®Æ½ÍŶÓÓëÇ廪´óѧÍò¿Æ¹«¹²ÎÀÉúÓ뿵½¡Ñ§Ôº¼Í˼º²ÍŶÓÁªºÏÔÚThe Lancet Regional Health ¨C Western Pacific½ÒÏþÌâΪ¡°Climate change and antimicrobial resistance in the Western Pacific: a mixed-methods systematic analysis¡±µÄÔ­´´ÐÔÑо¿Ð§¹û¡£¡£¸ÃÑо¿ÖÜȫչÏÖÁËÌìÆø×ª±ä¼Ó¾çÁËÎ÷̫ƽÑóµØÇø¿¹ÉúËØÄÍÒ©ÐÔ£¨antimicrobial resistance, AMR£©·çÏÕ£¬£¬²¢...

  • 06 2026-01

    ngµç×ÓÓÎÏ·ËïСǿ½ÌÊÚÍŶÓÑз¢Ï¸°ûͨѶËÙÂÊÄ£×Ó½âÂëϸ°û״̬Ñݱä¶à±ê×¼µ÷¿Ø»úÖÆ

    ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±ËïСǿ£©¿ËÈÕ£¬£¬ngµç×ÓÓÎÏ·ÊýѧѧԺËïСǿ½ÌÊÚÍŶÓÎ§ÈÆ¡°¶¯Ì¬Ï¸°û¼äͨѶ£¨cell¨Ccell communication, CCC£©ÔõÑùÇý¶¯Ï¸°û״̬ת±ä£¨cell state transition, CST£©¡±ÕâÒ»Òªº¦ÎÊÌ⣬£¬Ìá³öÁËÒ»¸öͳһµÄϸ°ûͨѶËÙÂÊÄ£×Ó¡ªCCCvelo£¬£¬¸ÃÄ£×ÓÊÇÒ»¸ö¶à±ê×¼·ÇÏßÐÔ¶¯Á¦Ñ§Ä£×Ó£¬£¬ÆäÕûºÏÁËϸ°û¼äÅäÌå-ÊÜÌåÐźÅÌݶȺÍϸ°ûÄÚת¼Òò×Ó¼¤»î¼¶Áª£¬£¬´Ó¶¯Á¦Ñ§²ãÃæÆÊÎö±àÂëϸ°û״̬ÑݱäµÄ»ùÒò±í´ï¶¯Ì¬¡£¡£½øÒ»²½£¬£¬Ñо¿ÍŶÓÌá³öÁËÒ»ÖÖ»ùÓÚ...

  • 29 2025-12

    ³Â•Fºþ¡¢¡¢Ã«ÈÊÍÅ¶ÓÆÆ½â³¦µÀÏËά»¯´úлÃÜÂë

    ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô± ¿µ¾þÃù£©Á¥ÊôµÚÒ»Ò½ÔºÏû»¯ÄڿƳ•Fºþ¡¢¡¢Ã«ÈÊÍŶÓͨ¹ý´úл×éѧ¡¢¡¢µ¥Ï¸°ûת¼×é¼°¿Õ¼äת¼×éµÈ¶à×éѧÕûºÏÆÊÎö£¬£¬·¢Ã÷Á×ËáÎìÌÇ;¾¶£¨pentose phosphate pathway, PPP£©ÔÚ¿ËÂÞ¶÷²¡£¡£¨CD£©ÏËά»¯³¦¶Î³ÉÏËάϸ°ûÖÐÏÔÖø¼¤»î£¬£¬ÆäÒªº¦´úл²úƷľͪÌÇ-5-Á×Ëᣨxylulose-5-phosphate£¬£¬Xu5P£©ÏÔ×ÅÉý¸ß£¬£¬²¢Ó볦µÀÏËά»¯¼²²¡ÑÏÖØ³Ì¶ÈÇ×½üÏà¹Ø¡£¡£ÔÚ»úÖÆÉÏ£¬£¬Ä¾ÍªÌǼ¤Ã¸£¨xylulokinase£¬£¬XYLB£©´ß»¯ÌìÉúµÄ Xu5P £¬£¬Í¨¹ý±í¹ÛÒÅ´«µ÷...

  • 24 2025-12

    ngµç×ÓÓÎÏ·ÀîöÁ½ÌÊÚÕ¹ÏÖPRDX6ÖúÁ¦GPX4ÂѰ×ÉÏĤÔöÇ¿Ö×Áöϸ°ûÌÓÒÝÌúéæÃüµÄлúÖÆ

    ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô± ÕÅÓñçù£©2025Äê12ÔÂ18ÈÕ£¬£¬ngµç×ÓÓÎÏ·ÖÐɽҽѧԺÀîöÁ½ÌÊÚ¡¢¡¢¹ãÖÝÒ½¿Æ´óѧÁõ½ð±£½ÌÊÚÓëÃÀ¹úµÂ¿ËÈøË¹´óÑ§ÌÆµÀÁÖ½ÌÊÚÍŶÓÏàÖú£¬£¬ÔÚMolecular CellÉϽÒÏþÁËÌâΪTargeting PRDX6-dependent localization and function of GPX4 enhances ferroptosis-mediated tumor suppressionµÄÑо¿Ð§¹û¡£¡£¸ÃÑо¿ÏµÍ³Õ¹ÏÖÁ˹ýÑõ»¯»¹Ô­Ã¸6£¨PRDX6£©½éµ¼µÄÌúéæÃü·ÀÓù»úÖÆ£¬£¬ÆÊÎöÁËÆäÁ¬Ïµ²¢Ð¯´øGPX4ÂѰ×ÉÏĤÔö½øÏ¸°ûĤÁ×Ö¬¹ýÑõ»¯ËðÉËÐÞ...

  • 22 2025-12

    ngµç×ÓÓÎÏ·ÖÜÒã½ÌÊÚÍŶÓÔÚ˯Ãß·ÖÆÚÁìÓòÈ¡µÃÐÂÏ£Íû

    ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨ ͨѶԱÕÅÓñçù£©¿ËÈÕ£¬£¬ngµç×ÓÓÎÏ·ÖÐɽҽѧԺÖÜÒã½ÌÊÚÍŶÓÔÚÖпÆÔºÒ»ÇøTOPÆÚ¿¯Knowledge-Based SystemsÔÚÏß½ÒÏþÌâΪ¡¶SleepECGFusion: A Cross-Modal Deep Learning Framework for Automatic Sleep Stage Classification using Single-Lead ECG¡·µÄÑо¿ÂÛÎÄ¡£¡£Ñо¿Ìá³öÁËÒ»ÖÖÁ¢ÒìÐÍ¿çģ̬Éî¶Èѧϰ¿ò¼Ü£¬£¬¸Ã¿ò¼ÜÀÖ³ÉÕûºÏÁËÀ´×ÔÁ½¸ö»¥²¹ÁìÓòµÄÐÅÏ¢¡£¡£Ñо¿ÑéÖ¤ÁËÔöÌíÊäÈëÐźųÖÐøÊ±¼äÄܹ»³ÖÐøÌá¸ßËùÓÐ˯Ã߽׶εķÖÀà׼ȷÂÊ...

  • 19 2025-12

    ngµç×ÓÓÎÏ··ëϼÍŶӿª·¢Î§ÊõÆÚ²¢·¢Ö¢ÖÇÄܼì²âϵͳ

    ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±¿µ¾þÃù£©¿ËÈÕ£¬£¬Á¥ÊôµÚÒ»Ò½ÔºÂé×í¿Æ·ëϼ½ÌÊÚÍŶÓÔÚΧÊõÆÚ²¢·¢Ö¢ÖÇÄܼì²âÁìÓòÈ¡µÃÖØ´óÍ»ÆÆ£¬£¬Ð§¹û½ÒÏþÓÚ¹ú¼Ê×ÅÃûÆÚ¿¯¡¶npjÊý×Öҽѧ¡·¡£¡£¸ÃÑо¿Ìá³ö"Õë¶ÔÐÔÕ½ÂÔ+LoRA΢µ÷"ÊÖÒÕõè¾¶£¬£¬Àֳɽ«Ð¡ÐÍ¿ªÔ´AIÄ£×ÓÌáÉýÖÁר¼Òˮƽ£¬£¬Îª×ÊÔ´ÊÜÏÞÒ½ÁÆ»ú¹¹Ìṩ¿ÉÂ䵨µÄÖÇÄÜ»¯½â¾ö·½°¸¡£¡£È«ÇòÿÄê2.3ÒÚÆÆÀý¿ÆÊÖÊõÖУ¬£¬Î§ÊõÆÚ²¢·¢Ö¢éæÃüÂÊ´ï1-4%¡£¡£¹Å°åÈ˹¤¼ì²â±£´æÑÏÖØÈ±ÏÝ£º27%δ±»¼Í¼£¬£¬10%·ÖÀà¹ýʧ¡£¡£Ö»¹Ü´óÓïÑÔÄ£×ÓÕ¹ÏÖÖØ´óDZÁ¦...

  • 17 2025-12

    ngµç×ÓÓÎÏ·³Ì³¬ÍŶÓÕ¹ÏÖ·ÇСϸ°û·Î°©ÃâÒßÖÎÁÆÄÍҩлúÖÆ

    ngµç×ÓÓÎÏ·ÐÂÎÅÍøÑ¶£¨Í¨Ñ¶Ô±¿µ¾þÃù£©ngµç×ÓÓÎÏ·Á¥ÊôµÚÒ»Ò½ÔºÐØÍâ¿Æ³Ì³¬½ÌÊÚÍŶÓÕë¶ÔÄ¿½ñÃâÒßÖÎÁƱê¼ÇÎïȱ·¦¡°ÖÎÁÆÌØÒìÐÔ¡±µÄÄÑÌ⣬£¬Ê¹Ó÷ÇСϸ°û·Î°©£¨NSCLC£©ÃâÒßÖÎÁÆË«±ÛËæ»ú±ÈÕÕÁÙ´²ÊÔÑ飨OAKºÍPOPLARÐÐÁУ©Êý¾Ý£¬£¬½¨ÉèÁËÒ»Ì×ÑÏ¿áµÄɸѡ¿ò¼Ü£¬£¬Ê״ν«´úлת¼×é³ÌÐòϵͳÐÔÇø·ÖΪ¡°ÃâÒßÖÎÁÆÌØÒìÐÔÔ¤²âÒò×Ó¡±¡¢¡¢¡°»¯ÁÆÌØÒìÐÔÔ¤²âÒò×Ó¡±¡¢¡¢¡°·ÇÌØÒìÐÔÔ¤ºóÒò×Ó¡±Óë¡°ÎÞ¹ØÒò×Ó¡±¡£¡£Ïà¹ØÑо¿½ÒÏþÔÚ¹ú¼ÊÄÍÒ©ÐÔÑо¿È¨ÍþÆÚ¿¯¡¶Drug Resistance Updat...

  • 15 2025-12

    ngµç×ÓÓÎÏ·Óëͬ¼ÃÒ½Ôº¿ÆÑÐÍŶÓÁªºÏ·¢Ã÷¿¹ÒÖÓôÒ©ÔöÇ¿Âѳ²°©»¯ÁÆÃô¸ÐÐÔµÄ×÷ÓûúÖÆ

    ngµç×ÓÓÎÏ·ÐÂÎÅÍø£¨Í¨Ñ¶Ô± ÕÅÓñçù£©¿ËÈÕ£¬£¬ngµç×ÓÓÎÏ·ÖÐɽҽѧԺÉú»¯ÏµÅ˳¬ÔÆÍŶÓ£¬£¬ÁªºÏÖÐɽһԺ¸¾¿ÆÁõ¾üÐã¡¢¡¢Àî½àÍŶӼ°»ªÖпƼ¼´óѧͬ¼ÃÒ½Ôº¸¾¿Æ¸ßÇìÀÙÍŶÓ£¬£¬ÔÚCell Metabolism½ÒÏþÌâΪ¡°Serotonin-licensed macrophages potentiate chemoresistance via inositol metabolic crosstalk in ovarian cancer¡±µÄÑо¿£¬£¬Ê×´ÎÕ¹ÏÖÍâÖÜѪÇåËØ£¨5-HT£©Í¨¹ýÖ×ÁöÏà¹Ø¾ÞÊÉϸ°û£¨TAM£©ÔöÇ¿Ö×Áöϸ°ûDNAÍ¬Ô´ÖØ×éÐÞ¸´¡¢¡¢µ¼ÖÂÂѳ²°©»¯ÁÆÄÍÒ©µÄ×÷Óûú...

¡¾ÍøÕ¾µØÍ¼¡¿